Famous trademark of Hunan Province, executive director of China Health Industry Council, medical institution listed on IPO earlier in China, and ophthalmic medical chain institution with characteristic strength and scale
Aier Eye Hospital Group is a leading ophthalmic medical chain in China, and an IPO-listed medical institution (stock code: 300015, selected as a stock in the CSI 300 Index in 2015). As of June 2017, more than 180 professional ophthalmology hospitals have been established in 30 provinces and municipalities across the country, covering more than 70% of the national medical insurance population and more than 4 million outpatient clinics per year. In addition, ophthalmology branches are also established in Hong Kong and the United States.
Aier Ophthalmology is committed to introducing and absorbing international synchronized ophthalmic technology and medical management concepts, and promoting the development of China's ophthalmic medical industry with the development strategy of specialization, scale and science.
Through continuous exploration and practice, and on the basis of fully absorbing the international advanced medical management experience, we have successfully explored a set of ophthalmic hospital chain management model that adapts to China's national conditions and market environment - "hierarchical chain". By taking advantage of talents, technology and management, Aier Ophthalmology has become a trusted eye hospital for ophthalmology patients all over the country through the good diagnosis and treatment quality, high-quality medical services and professional marketing of chain hospitals across the country.
In 2013, Aier Eye Hospital Group and Central South University jointly established a professional ophthalmology medical school, Aier School of Ophthalmology, Central South University, which mainly cultivates senior medical talents with master's and doctoral degrees in ophthalmology. In 2014, Aier School of Optometry was jointly established with Hubei University of Science and Technology. In 2011 and 2015, Aier Ophthalmology successively established "Aier Optometry Institute" and "Aier Eye Research Institute". So far, Aier Ophthalmology has opened up the three major fields of ophthalmology, learning and research, and the establishment of the college and research institute will significantly improve the scientific research and clinical level of Aier Ophthalmology, and promote the development and progress of China's ophthalmic medical industry.
As of 2016, Aier Ophthalmology has a team of nearly 3,000 professional ophthalmology experts and doctors, including a large number of master's supervisors, doctoral supervisors, doctors, postdoctoral fellows, scholars studying in Europe and the United States, and core experts with rich clinical experience, which is a high-profile force in the field of ophthalmology in China.
On July 9, 2014, World Bank President Jim Yong Kim visited Aier Ophthalmology Changsha Hospital and promoted Aier Ophthalmology's unique sustainable philanthropic model in developing countries around the world. In 2015, Aier Ophthalmology acquired Hong Kong Asia Medical Group, opening the pace of internationalization of Aier Ophthalmology, and in 2017, Aier Ophthalmology acquired a well-known ophthalmology center in the United States, marking a new step in internationalization.
Through the pioneering "cross-subsidy" model, on the one hand, Aier Ophthalmology provides patients with higher quality ophthalmic medical services, and at the same time comprehensively carries out blindness prevention and treatment, devotes itself to social welfare and helps vulnerable groups, and unites all sectors of society to promote the comprehensive development of the whole China's blindness prevention cause.
With the further advancement of China's medical and health system reform, Aier Ophthalmology conforms to the national medical and health policy and development trend, and launched the "Partner Program" in the medical industry in 2014, which is committed to changing the ecological environment of ophthalmologists' practice and maximizing the creativity and initiative of core backbones. Aier Ophthalmology focuses on ophthalmic medical services, and is expected to build 200 competitive professional chain ophthalmic hospitals by 2017 to provide high-quality, multi-level ophthalmic medical services for more people.
